Somalogic Operating Co., Inc.
Records under this name other than the patents Somalogic Operating Co., Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 58 patents it holds.
Back to Somalogic Operating Co., Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,927,380 | Oligonucleotides Comprising Modified Nucleosides Formerly held In force · High confidence | In force | High confidence | |
| US 12,180,482 | Oligonucleotides Comprising Modified Nucleosides Formerly held In force · High confidence | In force | High confidence | |
| US 11,578,330 | Oligonucleotides Comprising Modified Nucleosides Formerly held In force · High confidence | In force | High confidence | |
| US 9,994,857 | PDGF and VEGF aptamers having improved stability and their use in treating PDGF and VEGF mediated diseases and disorders Lapsed on the fee record Ended Jun 12, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2026 | From the USPTO record |
| US 8,703,416 | Method for purification and identification of sperm cells Lapsed on the fee record Ended Apr 22, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 22, 2026 | From the USPTO record |
| US 11,249,080 | Proteomic assay using quantum sensors Lapsed on the fee record Ended Feb 15, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 15, 2026 | From the USPTO record |
| US 8,598,140 | Aptamers to Beta-NGF and Their Use in Treating Beta-NGF Mediated Diseases and Disorders Lapsed on the fee record Ended Dec 3, 2025 · High confidence | Lapsed on the fee record | Ended Dec 3, 2025 | High confidence |
| US 11,041,866 | Pancreatic Cancer Biomarkers and Uses Thereof Lapsed on the fee record Ended Jun 22, 2025 · High confidence | Lapsed on the fee record | Ended Jun 22, 2025 | High confidence |
| US 10,808,251 | Nucleic acid compounds for binding growth differentiation factor 11 Lapsed on the fee record Ended Oct 20, 2024 · From the USPTO record | Lapsed on the fee record | Ended Oct 20, 2024 | From the USPTO record |
| US 8,071,734 | Nucleic acid-based detection Term ended Term ended Mar 13, 2023 · From the USPTO record | Term ended | Term ended Mar 13, 2023 | From the USPTO record |